BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31829429)

  • 1. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
    Ruan H; Li Y; Wang X; Sun B; Fang W; Jiang S; Liang C
    Jpn J Clin Oncol; 2020 Mar; 50(3):254-260. PubMed ID: 31829429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
    Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
    Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
    Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.
    Huang Z; Cheng Y; Chiu PM; Cheung FM; Nicholls JM; Kwong DL; Lee AW; Zabarovsky ER; Stanbridge EJ; Lung HL; Lung ML
    Oncogene; 2012 Aug; 31(32):3709-20. PubMed ID: 22158051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells.
    Zhang X; Lin J; Ma Y; Zhao J
    Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
    Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC
    Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
    Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
    Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
    Ni M; Zhao Y; Wang X
    Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
    Shi C; Yang X; Bu X; Hou N; Chen P
    Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription.
    Wu K; Fan J; Zhang L; Ning Z; Zeng J; Zhou J; Li L; Chen Y; Zhang T; Wang X; Hsieh JT; He D
    Cell Signal; 2012 Dec; 24(12):2273-82. PubMed ID: 22906492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells.
    Wang X; Zhang R; Wu T; Shi Y; Zhou X; Tang D; Yu W; So EC; Wu X; Pan Z; Tian J
    Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):238-248. PubMed ID: 33410473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.